IPX203

Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...

PARIS, June 30, 2026 Sanofi has announced that its enzyme replacement therapy Nexviazyme® (avalglucosidase alfa) successfully met all primary...

BRESSO, Milan, Italy, June 29, 2026 Zambon has announced that the Committee for Medicinal Products for Human Use (CHMP)...